IMPAD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.997800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.476000E-01
Normal-vs-Stage2
6.369600E-01
Normal-vs-Stage3
5.461400E-01
Normal-vs-Stage4
3.552600E-01
Stage1-vs-Stage2
7.164200E-01
Stage1-vs-Stage3
1.202020E-01
Stage1-vs-Stage4
6.445600E-01
Stage2-vs-Stage3
2.330800E-01
Stage2-vs-Stage4
4.317600E-01
Stage3-vs-Stage4
1.104960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.887800E-01
Normal-vs-AfricanAmerican
7.313000E-01
Normal-vs-Asian
9.256800E-01
Caucasian-vs-AfricanAmerican
8.911800E-01
Caucasian-vs-Asian
2.342600E-01
AfricanAmerican-vs-Asian
5.409400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.369800E-01
Normal-vs-Female
5.316800E-01
Male-vs-Female
9.848800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.891200E-01
Normal-vs-Age(41-60Yrs)
3.082600E-01
Normal-vs-Age(61-80Yrs)
7.037800E-01
Normal-vs-Age(81-100Yrs)
9.911800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.467800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.235700E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.668000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.902100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.559600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.633800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.418600E-01
Normal-vs-Daily Drinker
9.364600E-01
Normal-vs-Weekly Drinker
6.508400E-01
Normal-vs-Occasional Drinker
5.133600E-01
Normal-vs-Social Drinker
4.925200E-01
Non Drinker-vs-Daily Drinker
9.592400E-01
Non Drinker-vs-Weekly Drinker
4.410600E-01
Non Drinker-vs-Occasional Drinker
1.705020E-01
Non Drinker-vs-Social Drinker
1.319600E-01
Daily Drinker-vs-Weekly Drinker
5.523600E-01
Daily Drinker-vs-Occasional Drinker
2.094600E-01
Daily Drinker-vs-Social Drinker
2.213800E-01
Weekly Drinker-vs-Occasional Drinker
5.062800E-01
Weekly Drinker-vs-Social Drinker
5.116000E-01
Occasional Drinker-vs-Social Drinker
9.762800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.706800E-01
Normal-vs-Grade 2
7.423900E-02
Normal-vs-Grade 3
1.446820E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.531800E-01
Grade 1-vs-Grade 3
9.187600E-01
Grade 1-vs-Grade 4
2.706800E-01
Grade 2-vs-Grade 3
7.913200E-01
Grade 2-vs-Grade 4
7.423900E-02
Grade 3-vs-Grade 4
1.446820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.910800E-01
Normal-vs-NonDiabetic
6.475600E-01
Diabetic-vs-NonDiabetic
5.072000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.055400E-01
Normal-vs-NoPancreatitis
6.220800E-01
Pancreatitis-vs-NoPancreatitis
5.710400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.755000E-01
Normal-vs-N1
6.022000E-01
N0-vs-N1
5.610200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.179200E-01
Normal-vs-TP53-NonMutant
6.692400E-01
TP53-Mutant-vs-TP53-NonMutant
3.694800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
